HELP Study - Towards High Throughput and Efficient Long-axial PET With Oral [18F]FDG

Recruiting N/A Interventional Study
Multiple Cancers Multiple Indications Cancer Feasibility Studies
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
19 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
27 (estimated)
Sponsor
British Columbia Cancer Agency · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Typically, PET scans involve an IV injection of 18F-FDG that helps identify cancer. Patients are scanned 60 minutes after injecting 18F-FDG. This study aims to assess the feasibility of a different method of administration - oral ingestion (rather than IV) of 18F-FDG through delayed imaging to identify the optimal time for scanning after consuming the drug. The study will aim to recruit 15-24 indi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥19 years * Participants who have received a standard of care \[18F\]FDG PET/CT and are willing to undergo a study specific oral \[18F\]FDG PET/CT within 2 weeks. Exclusion Criteria: Participant Inclusion Criteria * Age ≥19 years * Participants who have received a stand…
Contacts

Pavithraa Administrative Research Manager

6048776000

pavithraa.ravi@bccancer.bc.ca

CONTACT